share_log

4: Statement of changes in beneficial ownership of securities-Director Harrington-Smith Kristen

4: Statement of changes in beneficial ownership of securities-Director Harrington-Smith Kristen

4:持股變動聲明-董事 Harrington-Smith Kristen
美股SEC公告 ·  06/13 18:24
Moomoo AI 已提取核心訊息
In a recent transaction, Kristen Harrington-Smith, associated with eFFECTOR Therapeutics, Inc. (EFTR), executed a stock transaction on June 13, 2024. The specific details regarding the nature of the shares, the number of shares transacted, the transaction price, and the post-transaction shareholding were not disclosed. This financial activity pertains directly to eFFECTOR Therapeutics, a company trading under the symbol EFTR on the stock market.
In a recent transaction, Kristen Harrington-Smith, associated with eFFECTOR Therapeutics, Inc. (EFTR), executed a stock transaction on June 13, 2024. The specific details regarding the nature of the shares, the number of shares transacted, the transaction price, and the post-transaction shareholding were not disclosed. This financial activity pertains directly to eFFECTOR Therapeutics, a company trading under the symbol EFTR on the stock market.
近期,與eFFECTOR Therapeutics, Inc. (EFTR)相關人員Kristen Harrington-Smith於2024年6月13日進行了一筆股票交易。關於股票的性質、交易數量、交易價格和交易後的持股情況等具體細節未披露。這項金融活動直接涉及eFFECTOR Therapeutics這家在股票市場上以EFTR爲標的進行交易的公司。
近期,與eFFECTOR Therapeutics, Inc. (EFTR)相關人員Kristen Harrington-Smith於2024年6月13日進行了一筆股票交易。關於股票的性質、交易數量、交易價格和交易後的持股情況等具體細節未披露。這項金融活動直接涉及eFFECTOR Therapeutics這家在股票市場上以EFTR爲標的進行交易的公司。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息